Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:42:49 +0200Fri, 28 Jun 2024 14:46:00 +0200Vizamyl : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2557-steps-after_en_0.pdfVizamyl : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2557-steps-after_en_0.pdfFri, 28 Jun 2024 14:46:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vizamylHuman medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vizamylFri, 28 Jun 2024 14:44:00 +0200Human medicine